Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sasamata

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
European Journal of Pharmacology|January 3, 1991
Effects of YM-14673, a new thyroid-releasing hormone analogue, on neurological deficits in stroke-prone spontaneously hypertensive ratsM Yamamoto, K Sudoh, M Sasamata
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 6, 2000
[New method for evaluating the effects of neuroprotective therapy in the hemodynamic penumbra]M Sasamata, M A Moskowitz, E H Lo
International Journal of Clinical Pharmacology Research|May 4, 2005
Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockersH Kakuta, K Sudoh, M Sasamata, et al.
European Journal of Pharmacology|May 16, 1990
Central dopaminergic actions of YM-14673, a new TRH analogue, in rodentsM Yamamoto, Y Ozawa, M Sasamata, et al.
Annals of Medicine|January 1, 1990
Association between tissue plasminogen activator and serum lipids in healthy volunteersR Yamada, S Yamada, A Ishii, et al.
Inflammopharmacology|February 27, 2007
Pharmacological profile of ramosetron, a novel therapeutic agent for IBST Hirata, T Funatsu, Y Keto, et al.
Brain Research|April 28, 2001
Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's diseaseK Terai, A Iwai, S Kawabata, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
Possible involvement of central cholinergic system in ameliorating effects of indeloxazine, a cerebral activator, on disturbance of learning behavior in ratsM Yamamoto, K Takahashi, M Ohyama, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1990
[t-PA activity, antigen and PAI-1 antigen levels in blood obtained from the patients with cerebral infarction]S Yamada, R Yamada, A Ishii, et al.
The Journal of Antibiotics|September 1, 1989
Novel antitumor antibiotic phospholine. 2. Structure determinationT Ozasa, K Tanaka, M Sasamata, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Journal of Pharmacology|January 3, 1991
Effects of YM-14673, a new thyroid-releasing hormone analogue, on neurological deficits in stroke-prone spontaneously hypertensive ratsM Yamamoto, K Sudoh, M Sasamata
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 6, 2000
[New method for evaluating the effects of neuroprotective therapy in the hemodynamic penumbra]M Sasamata, M A Moskowitz, E H Lo
International Journal of Clinical Pharmacology Research|May 4, 2005
Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockersH Kakuta, K Sudoh, M Sasamata, et al.
European Journal of Pharmacology|May 16, 1990
Central dopaminergic actions of YM-14673, a new TRH analogue, in rodentsM Yamamoto, Y Ozawa, M Sasamata, et al.
Annals of Medicine|January 1, 1990
Association between tissue plasminogen activator and serum lipids in healthy volunteersR Yamada, S Yamada, A Ishii, et al.
Inflammopharmacology|February 27, 2007
Pharmacological profile of ramosetron, a novel therapeutic agent for IBST Hirata, T Funatsu, Y Keto, et al.
Brain Research|April 28, 2001
Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's diseaseK Terai, A Iwai, S Kawabata, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
Possible involvement of central cholinergic system in ameliorating effects of indeloxazine, a cerebral activator, on disturbance of learning behavior in ratsM Yamamoto, K Takahashi, M Ohyama, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1990
[t-PA activity, antigen and PAI-1 antigen levels in blood obtained from the patients with cerebral infarction]S Yamada, R Yamada, A Ishii, et al.
The Journal of Antibiotics|September 1, 1989
Novel antitumor antibiotic phospholine. 2. Structure determinationT Ozasa, K Tanaka, M Sasamata, et al.
Pageof 2